Zogenix Inc (NASDAQ:ZGNX)’s share price plunged -2.43% or -0.97 to reach at $39.03 during previous trading session. A total of 1.57 Million shares exchanged hands, whereas the company’s average trading volume stands at 707.32 Million shares. Zogenix Inc (NASDAQ:ZGNX) has a market capitalization of $1.63 Billion and most recently 41.82 Million outstanding shares have been calculated.

According to sentiments of 10 analysts the mean estimates of short term price target for the company’s stock is marked at $59.4. The most optimistic analyst sees the stock reaching $92 while the most conventional predicts the target price at $40.

In terms of Buy/Sell recommendations, 9 analysts have a consensus rating of 1.22 on the shares of Zogenix Inc (NASDAQ:ZGNX). Out of rating recommendations 6 have given the stock a Buy while 4 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Zogenix Inc (NASDAQ:ZGNX)’s shares slipped -24.23% in the past week and plunged -26.32% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -4.69% while its year to date performance is at 7.05%.

While taking a glance at financials, we can look at a number of key indicators. Zogenix Inc (NASDAQ:ZGNX) has a Return on Assets (ROA) of -23.7. The company currently has a Return on Equity (ROE) of -30.7 and a Return on Investment (ROI) of 0. Average true range (ATR-14) of the company sets at 2.67, along with its weekly and monthly volatility of 4.60% and 4.09% respectively. Relative strength index (RSI-14) for Zogenix Inc (NASDAQ:ZGNX) is at 21.09. Beta value of the stock stands at 2.14.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 0 along with current ratio for most recent quarter of 9.1. Total debt to equity ratio of Zogenix Inc (NASDAQ:ZGNX) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of Dynavax Technologies (NASDAQ:DVAX) plunged -1.27% or -0.09 to reach at $7.01 during previous trading session. Dynavax Technologies (NASDAQ:DVAX) has a market capitalization of $439.46 Million and most recently 62.69 Million outstanding shares have been calculated. A total of 872545 shares exchanged hands, whereas the company’s average trading volume stands at 1.12 Million shares.

According to 4 analysts Dynavax Technologies (NASDAQ:DVAX)’s price will reach at $30.75 during 52 weeks. Stock’s minimum price target estimates has been figured out at $23 while the maximum price target forecast is established at $42.

According to the recommendations from 5 analysts stock has mean rating of 1.2 on the shares of Dynavax Technologies (NASDAQ:DVAX). Out of rating recommendations 1 have given the stock a Buy while 4 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Dynavax Technologies (NASDAQ:DVAX) slipped -2.64% in the past week and plunged -16.75% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -37.35% while its year to date performance is at -23.39%.

Total debt to equity ratio of Dynavax Technologies (NASDAQ:DVAX) for most recent quarter is 1.6 whereas long term debt to equity ratio for most recent quarter is 1.6. The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 4.1 along with current ratio for most recent quarter of 4.6.

Average true range (ATR-14) of the company sets at 0.37, along with its weekly and monthly volatility of 3.56% and 5.27% respectively. Relative strength index (RSI-14) for Dynavax Technologies (NASDAQ:DVAX) is at 34.06. Beta value of the stock stands at 0.68. Dynavax Technologies (NASDAQ:DVAX) has a Return on Assets (ROA) of -63.2. The company currently has a Return on Equity (ROE) of -139 and a Return on Investment (ROI) of -93.5.